当前位置：
X-MOL 学术
›
J. Hepatocell. Carcinoma
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study
Journal of Hepatocellular Carcinoma ( IF 4.1 ) Pub Date : 2021-07-28 , DOI: 10.2147/jhc.s308587 Yi Yang 1 , Yanzhao Zhou 2, 3 , Xinyuan Zhang 1 , Yujing Xin 1 , Yi Chen 1, 4 , Qingsheng Fan 5 , Xiao Li 1 , Xi Wei 6 , Qiang Li 3 , Xiang Zhou 1 , Jinxue Zhou 2
Journal of Hepatocellular Carcinoma ( IF 4.1 ) Pub Date : 2021-07-28 , DOI: 10.2147/jhc.s308587 Yi Yang 1 , Yanzhao Zhou 2, 3 , Xinyuan Zhang 1 , Yujing Xin 1 , Yi Chen 1, 4 , Qingsheng Fan 5 , Xiao Li 1 , Xi Wei 6 , Qiang Li 3 , Xiang Zhou 1 , Jinxue Zhou 2
Affiliation
Objective: This study was conducted to explore the application of age-male-ALBI-platelets (aMAP) score for predicting late recurrence of hepatocellular carcinoma (HCC) following radiofrequency ablation (RFA) and develop an aMAP score based-nomogram to predict prognosis in Chinese population.
Materials and Methods: HCC patients who developed late recurrence following RFA at National Cancer Center (NCC) of China, First Hospital of Shanxi Medical University and Beijing Hospital of Traditional Chinese Medicine from January 2011 to December 2016 were included as a training cohort, and patients who were treated at Affiliated Cancer Hospital of Zhengzhou University between January 2012 and December 2016 were included as an external validation cohort. The optimal cut-off value for aMAP score was determined using X-tile software to discriminate the performance of recurrence-free survival (RFS).
Results: A total of 339 eligible patients were included in this study. Patients were grouped into low-risk (aMAP score ≤ 64.2), medium-risk (64.3 ≤aMAP score ≤ 68.6) and high-risk (aMAP score ≥ 68.7) groups by X-tile plots. The prognostic factors that affected RFS were the number of lesions and aMAP score. A nomogram was constructed to predict the RFS with a C-index of 0.793 (95% CI: 0.744– 0.842). The time-dependent receiver operating characteristic curves (t-AUCs) of the nomogram to predict 3, 4 and 5-year RFS were 0.808, 0.820 and 0.764, respectively. The model was then tested with data from an external validation cohort. The calibration curve confirmed the optimal agreement between the predicted and observed values.
Conclusion: The aMAP score provided a well-discriminated risk stratification and is an independent prognostic factor for the late recurrence of HCC following RFA. The aMAP score-based nomogram could help to strengthen prognosis-based decision making and formulate adjuvant therapeutic and preventive strategies.
Keywords: hepatocellular carcinoma, radiofrequency ablation, recurrence-free survival, age-male-ALBI-platelets score
更新日期：2021-07-27
Materials and Methods: HCC patients who developed late recurrence following RFA at National Cancer Center (NCC) of China, First Hospital of Shanxi Medical University and Beijing Hospital of Traditional Chinese Medicine from January 2011 to December 2016 were included as a training cohort, and patients who were treated at Affiliated Cancer Hospital of Zhengzhou University between January 2012 and December 2016 were included as an external validation cohort. The optimal cut-off value for aMAP score was determined using X-tile software to discriminate the performance of recurrence-free survival (RFS).
Results: A total of 339 eligible patients were included in this study. Patients were grouped into low-risk (aMAP score ≤ 64.2), medium-risk (64.3 ≤aMAP score ≤ 68.6) and high-risk (aMAP score ≥ 68.7) groups by X-tile plots. The prognostic factors that affected RFS were the number of lesions and aMAP score. A nomogram was constructed to predict the RFS with a C-index of 0.793 (95% CI: 0.744– 0.842). The time-dependent receiver operating characteristic curves (t-AUCs) of the nomogram to predict 3, 4 and 5-year RFS were 0.808, 0.820 and 0.764, respectively. The model was then tested with data from an external validation cohort. The calibration curve confirmed the optimal agreement between the predicted and observed values.
Conclusion: The aMAP score provided a well-discriminated risk stratification and is an independent prognostic factor for the late recurrence of HCC following RFA. The aMAP score-based nomogram could help to strengthen prognosis-based decision making and formulate adjuvant therapeutic and preventive strategies.
Keywords: hepatocellular carcinoma, radiofrequency ablation, recurrence-free survival, age-male-ALBI-platelets score
京公网安备 11010802027423号